focus -WSS

focus

author：leisure time 2025-10-02 23:59:38 - browse：32

om DiLenge (CQ in grey suit ) Flagship Pioneering Cambridge with US Congressman Raja Krishnamoorthi of Illinois were talking together at the event. Biotech companies demonstrating their medicines and materials at a "tech fair" designed to showcase the need to compete with Chinese biotech held at Harvard Kennedy School in Cambridge. The growing US backlash against the perceived national security threat posed by China's rising biotech industry — Tom DiLenge of Flagship Pioneering (left) with U.S. Congressman Raja Krishnamoorthi of Illinois at a "tech fair" designed to showcase the need to compete with Chinese biotech held at Harvard Kennedy School in Cambridge, Mass. David L Ryan/The Boston Globe

CAMBRIDGE, Mass. — The increasingly adversarial relationship between the United States and China has raised national security concerns about Chinese penetration into key sectors of the U.S. economy, such as technology, manufacturing, and clean energy.

Now, some in Congress are raising alarms about China’s threat to another vital industry: biotechnology.

A bipartisan group of lawmakers visited Massachusetts this week to call attention to that threat and call for strengthening U.S. life sciences companies, protecting their technologies, and safeguarding Americans’ genetic data from a Chinese biotech industry with close ties to the authoritarian state.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： An innovative path out of biotech’s “valley of death”

focus

WSS

Faced with fears of OxyContin misuse, sales reps touted its safety

PBMs are inflating the cost of generic drugs. They must be reined in

Maui funeral service workers on devastation of fires: 'I'm in shock'

Roche's accidental data boosts hopes for anti

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Timeline: Special counsel's investigation into Trump's handling of classified documents

focus

focus

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Intellia plays down concerns on accidental germline transmission

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Roche's accidental data boosts hopes for anti

Jerome Adams on the need for new antivirals for Covid

Kellogg’s is going to war over Mexico’s nutrition label rules

Medicare proposal to cover medical devices draws a mixed reaction

Intellia plays down concerns on accidental germline transmission

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

How the drug

focus

People can get long Covid without testing positive for virus: Study

Pharma budget tightening trickles down to Doximity

Listen: Vivek Ramaswamy's star turn & leaky drug data

Former Pear Therapeutics executives start new VC firm

The perfect storm of weather conditions that led to the devastating wildfires in Maui

Novo acquires Inversago for up to $1 billion

leisure time

entertainment

focus

Wikipedia